| abstract |
The present invention provides a non-aqueous external preparation containing dexmedetomidine that can inhibit the crystallization of dexmedetomidine in the preparation and has good transdermal absorbability. A non-aqueous external preparation containing (A) dexmedetomidine or its salt, (B) aliphatic alcohol with 10 to 12 carbons, (C) fatty acid ester with propylene glycol with 6 to 16 carbon atoms, (D) ) Organic acids and (E) organic acid salts. |